Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection

Clinical trial NCT04367883 · RECRUITING

Trial details

NCT number: NCT04367883
Sponsor: Consorci Sanitari de Terrassa
Status: RECRUITING
Study type: OBSERVATIONAL

COVID19 Influenza Vaccination ACE Inhibitors ARB Antihistamine Allergy Amantadine

Start date: 2020-03-01
Primary completion: 2025-01-19
Enrollment: 3000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.